Impaired brain protein drives fat cravings and obesity in mice
Repercussão envolvendo fonte internacional chama atenção em Fitness.
Notícias
Acompanhe as Notícias da Recifes
Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.
Most patients with obesity don't get the weight counseling they need, say researchers
There's no shortage of weight-loss advice on social media, TikTok, television and AI chatbots. But the most credible source—a patient's own primary care doctor—is often the one they're not hearing from.
Reinitiating obesity meds after bariatric surgery tied to greater one-year weight loss in youths
Restarting obesity medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, soon after sleeve gastrectomy (SG) is associated with greater one-year weight loss than surgery alone in adolescents, according to a research letter published online July 22 in JAMA Surge
Improving inpatient diabetes care with team approach that puts safety first
UC Davis Health has significantly and sustainably improved inpatient glycemic care through a coordinated, system-wide approach, according to a study published in Diabetes, Obesity, and Cardiometabolic Care.
People carrying a rare gene variant have naturally low body fat, healthier livers and bett
There are people around us who can maintain their weight despite what they eat. This has led scientists to believe that a person's metabolism and tendency toward obesity may have genetic factors behind them. A large study sequencing the genomes of more than 1 million people acros
Unexpected brain mechanism challenges assumptions about GLP-1s
For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10% to 15% or more. Despite their success, however, scientists have not fully understood how t
New GLP-1 pill delivers up to 12% weight loss in 36 weeks
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks. Unlike injectable drugs such as Wegovy and Ozempic, aleniglipron is a small molecule that can be taken once daily with or without food and could potent
Why choosing low-fat dairy is not necessarily better for your health
For years, we thought low-fat dairy was the way to manage obesity. New research is increasingly questioning this logic. O recorte ajuda a contextualizar a pauta dentro de Geral.
Traditional Japanese medicine may ease age-related fat tissue scarring
A traditional Japanese medicine used for obesity may do more than support weight loss. Researchers at the University of Osaka, working with Kobayashi Pharmaceutical Co., Ltd., investigated whether Bofutsushosan could protect aging tissues from fibrosis—the excessive buildup of sc
New recommendations address GLP-1 medications across women's reproductive years
As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to address one of medicine's most pressing unanswered questions: How should these medications be used b
Immune cells may hold the key to fighting obesity-induced muscle dysfunction
One of the many ways obesity harms the human body is through damage to skeletal muscle. This progressive muscle decline, also known as sarcopenia, reduces strength, mobility and the ability to live independently. Unfortunately, most therapies for obesity and related conditions li
Study: Obesity 'bigger cancer risk' than previously thought
A new study has found that being significantly overweight could be responsible for more cases of cancer than previously known. Abdominal fat, in particular, increases the risk of cancer — especially among women.